October 2, 2014     Japanese 
  JCN 
	  Network - Home
JCN Newswire
  Home  |  Companies  | Annual Reports  |  CSR  | News Alerts     
 
Share:
Daiichi Sankyo to Expand Antibody Drug Alliance with German Firm
 

 Daiichi Sankyo to Expand Antibody Drug Alliance with German Firm
Tokyo, Mar 26, 2008 (Jiji Press) - Japanese drug maker Daiichi Sankyo Co. <4568> said Wednesday it has agreed with a German biotechnology firm to expand their joint research on the development of antibody drugs.

Daiichi Sankyo and Munich-based MorphoSys AG, which launched the joint research in March 2006, will extend the period of their alliance until March 2011.

Under the extended contract, Daiichi Sankyo will be able to increase the number of antibody programs to a maximum of six per one target antigen, making use of a human antibody library developed by MorphoSys.

Daiichi Sankyo will pay fees to use the antibody library, as well as licensing fees and royalties to the German firm.

By Jiji Press, (c) Jiji Press

Copyright © 2014 JCN. All rights reserved. A division of Japan Corporate News Network KK.


 Company Profile |   Print  |   Alerts
ACN Newswire

 Recent  Daiichi Sankyo  News  
  Daiichi Sankyo Expands Collaborative Drug Discovery Program to Germany, Switzerland, and Austria  (Aug 1, 2013)
  Daiichi Sankyo Develops Nucleic Acid Treatment for Duchenne Muscular Dystrophy  (Feb 15, 2013)
  Daiichi Sankyo Introduces Alzheimer's Disease Awareness Campaign  (Dec 20, 2012)
  Daiichi Sankyo, Ranbaxy Launch Psteoporosis Medication EVISTA in Romania  (Sept 2, 2009)
  Daiichi Sankyo Files Application for Dysuria Treatment KMD-3213 in China  (Jan 8, 2009)
  Daiichi Sankyo and Ranbaxy Move Forward Toward The Completion of the Landmark Deal  (Oct 20, 2008)
  Daiichi Sankyo's Tender Offer for Ranbaxy Ends in Success  (Oct 17, 2008)
  Shionogi to Acquire U.S. Drug Maker Sciele Pharma  (Sept 1, 2008)
  Daiichi Sankyo to Buy Indian Drug Giant Ranbaxy  (June 11, 2008)
  Daiichi Sankyo to Acquire German Biomedical Firm  (May 21, 2008)



 Recent  Drugs & OTC News   
Mitsui to Participate in KIFMEC Specific Purpose Company (Aug 18, 2014)
Yokogawa Technology Selected for JSTA's Next-generation Technology Transfer Program (Aug 8, 2014)
Sysmex, Toppan Printing to Collaborate in Genetic Analysis Testing (June 9, 2014)
Takara Bio Submits IND Application to FDA for HF10 Anti-cancer Therapy (May 12, 2014)
Nitto Denko Anti-fibrosis Drug with Molecular Targeting DDS Completes Phase-1a Dose Escalation (Apr 24, 2014)
Kaneka, RIKEN Synthesize Bioplastic from Non-food Plant Resources
 (Apr 14, 2014)
Takara Bio Completes Enrollment for Phase I Clinical Trial in the US for HF10 Anti-Cancer Therapy (Apr 10, 2014)
Dainippon Sumitomo Pharma Establishes Anti-Cancer Drugs Sales Company in the U.S. (Oct 10, 2013)
EIZO, Stryker to Partner in Monitor Management Systems for Operating Rooms (Oct 8, 2013)
HOYA to Invest in EndoMaster, for Robotic-assisted Surgical Systems (Aug 19, 2013)

More Drugs & OTC news...
 
CSR Report Download
Annual Reports

  More >>    
Most Popular


About JCN | Privacy Policy | Terms of Use | JCN Network (日本語)